Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Arnitz (Vöcklabruck, Austria), M. Stein (Natters, Austria), P. Bauer (Natters, Austria), B. Lanthaler (Innsbruck, Austria), H. Jamnig (Natters, Austria), S. Scholl-Bürgi (Innsbruck, Austria), K. Stempfl-Al-Jazrawi (Innsbruck, Austria), H. Ulmer (Innsbruck, Austria), B. Baumgartner (Vöcklabruck, Austria), S. Embacher (Natters, Austria), S. Geisler (Innsbruck, Austria), J. Gostner (Innsbruck, Austria), B. Müllinger (Gauting, Germany), B. Kälz (Neufeld, Austria), M. Nagl (Innsbruck, Austria). Tolerability of anti-infective N-chlortaurine inhaled with a smart-nebuliser. 5461

Member's Comments

No comment yet.

Related content which might interest you: Efficacy and safety of high-dose inhaled corticosteroids therapy in children with asthma Source: Annual Congress 2010 - Allergy and risk factors in paediatrics Year: 2010 Co-dispensing of inhaled corticosteroids and antibiotics Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care Year: 2012 Oral steroid-sparing effect of high-dose inhaled corticosteroids in asthma Source: Eur Respir J, 55 (1) 1901147; 10.1183/13993003.01147-2019 Year: 2020 Safety of formoterol reliever therapy compared with terbutaline in asthmatic children taking anti-inflammatory therapy Source: Eur Respir J 2002; 20: Suppl. 38, 431s Year: 2002 Patterns of adherence to inhaled corticosteroids Source: International Congress 2019 – Inhalers: adherence and preference Year: 2019 Efficacy and safety of AZD3199, an inhaled ultra long-acting β2-agonist, in patients with COPD Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011 Efficacy of 12-month treatment with inhaled corticosteroid in bronchiectasis Source: Eur Respir J 2003; 22: Suppl. 45, 514s Year: 2003 Emerging inhaled bronchodilators: an update Source: Eur Respir J 2009; 34: 757 Year: 2009 Efficacy of inhaled ciclesonide compared with oral prednisolone in the treatment of asthma exacerbations Source: Eur Respir J 2006; 28: Suppl. 50, 206s Year: 2006 Concomitant use of low-dose inhaled corticosteroids and a long-acting bronchodilatator visavi doubling the dose of inhaled corticosterod in asthma patients Source: Eur Respir J 2001; 18: Suppl. 33, 98s Year: 2001 Integrating high dose inhaled corticosteroids into oral corticosteroids stewardship Source: Eur Respir J, 55 (1) 1902193; 10.1183/13993003.02193-2019 Year: 2020 Efficacy and safety of BI 671800, an oral CRTH2 antagonist, as add on therapy in poorly controlled asthma patients prescribed an inhaled corticosteroid Source: Annual Congress 2012 - New bronchodilators and other novel drugs for asthma and COPD Year: 2012 Efficacy and safety of BI 671800, an oral CRTH2 antagonist, as add on therapy in poorly controlled asthma patients prescribed an inhaled corticosteroid Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012 Response of children with bronchial asthma to combined therapy with an oral immunostimulating drug and antileukotrienes Source: Eur Respir J 2005; 26: Suppl. 49, 159s Year: 2005 Impact of the combination therapy: inhaled corticosteroid and long-acting beta agonists in the prescription pattern of inhaled corticosteroids Source: Annual Congress 2007 - Respiratory issues in primary care Year: 2007 Anti-inflammatory therapy COPD: fenspiride and(or) theophylline versus inhaled corticosteroids? Source: Annual Congress 2007 - Treatment of COPD Year: 2007 Pharmacodynamic effects of nebulised bronchodilator combinations Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020 Oral vs. inhaled antibiotic therapy Source: International Congress 2015 – Bronchiectasis in Europe: an update from the European Bronchiectasis Network (EMBARC) Year: 2015 Low systemic exposure of NVA237, an inhaled once-daily anticholinergic bronchodilator, in healthy humans Source: Eur Respir J 2006; 28: Suppl. 50, 661s Year: 2006 Efficacy of systemic corticosteroids in refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β2 agonist inhalation Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2010